These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

246 related items for PubMed ID: 30415952

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Interaction of MYC with host cell factor-1 is mediated by the evolutionarily conserved Myc box IV motif.
    Thomas LR, Foshage AM, Weissmiller AM, Popay TM, Grieb BC, Qualls SJ, Ng V, Carboneau B, Lorey S, Eischen CM, Tansey WP.
    Oncogene; 2016 Jul 07; 35(27):3613-8. PubMed ID: 26522729
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. The c-Myc oncogene directly induces the H19 noncoding RNA by allele-specific binding to potentiate tumorigenesis.
    Barsyte-Lovejoy D, Lau SK, Boutros PC, Khosravi F, Jurisica I, Andrulis IL, Tsao MS, Penn LZ.
    Cancer Res; 2006 May 15; 66(10):5330-7. PubMed ID: 16707459
    [Abstract] [Full Text] [Related]

  • 6. Histone demethylase PHF8 promotes epithelial to mesenchymal transition and breast tumorigenesis.
    Shao P, Liu Q, Maina PK, Cui J, Bair TB, Li T, Umesalma S, Zhang W, Qi HH.
    Nucleic Acids Res; 2017 Feb 28; 45(4):1687-1702. PubMed ID: 27899639
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. HER2 silences tumor suppression in breast cancer cells by switching expression of C/EBPß isoforms.
    Arnal-Estapé A, Tarragona M, Morales M, Guiu M, Nadal C, Massagué J, Gomis RR.
    Cancer Res; 2010 Dec 01; 70(23):9927-36. PubMed ID: 21098707
    [Abstract] [Full Text] [Related]

  • 12. Myc-induced proliferation and transformation require Akt-mediated phosphorylation of FoxO proteins.
    Bouchard C, Marquardt J, Brás A, Medema RH, Eilers M.
    EMBO J; 2004 Jul 21; 23(14):2830-40. PubMed ID: 15241468
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Identification of a novel c-Myc protein interactor, JPO2, with transforming activity in medulloblastoma cells.
    Huang A, Ho CS, Ponzielli R, Barsyte-Lovejoy D, Bouffet E, Picard D, Hawkins CE, Penn LZ.
    Cancer Res; 2005 Jul 01; 65(13):5607-19. PubMed ID: 15994933
    [Abstract] [Full Text] [Related]

  • 15. Necdin is a breast cancer metastasis suppressor that regulates the transcription of c-Myc.
    Lee M, Beggs SM, Gildea D, Bupp S, Lichtenberg J, Trivedi NS, NISC Comparative Sequencing Program, Hu Y, Bodine DM, Crawford NP.
    Oncotarget; 2015 Oct 13; 6(31):31557-68. PubMed ID: 26384308
    [Abstract] [Full Text] [Related]

  • 16. Ubiquitin-Dependent Turnover of MYC Antagonizes MYC/PAF1C Complex Accumulation to Drive Transcriptional Elongation.
    Jaenicke LA, von Eyss B, Carstensen A, Wolf E, Xu W, Greifenberg AK, Geyer M, Eilers M, Popov N.
    Mol Cell; 2016 Jan 07; 61(1):54-67. PubMed ID: 26687678
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Ad E1A 243R oncoprotein promotes association of proto-oncogene product MYC with the NuA4/Tip60 complex via the E1A N-terminal repression domain.
    Zhao LJ, Loewenstein PM, Green M.
    Virology; 2016 Dec 07; 499():178-184. PubMed ID: 27664947
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.